Rare Disease Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...

The probability of survival at the end of the follow-up period was significantly lower in patients with cardiac amyloidosis undergoing transcatheter aortic valve replacement (TAVR). Transcatheter ...

Cardiac scintigraphy had higher sensitivity and specificity across different radiotracers in diagnosing cardiac amyloidosis compared to cardiac magnetic resonance imaging. Cardiac scintigraphy, ...

NMOSD is a rare autoimmune disorder characterized by inflammation and demyelination of nerves in the central nervous system (CNS), particularly the optic nerves and spinal cord. It typically manifests ...

The vast capabilities of artificial intelligence mean that it can applied to various domains of medicine, including in the rare disease space. To much of the public, artificial intelligence (AI) may ...

An ongoing open-label extension study suggests that the therapy's benefits may extend through at least 52 weeks. Deupirfenidone (LYT-100), a next-generation antifibrotic therapy, demonstrated a ...

The risks of end-stage renal disease (ESRD) and kidney transplant infection were lower in patients who used SGLT-2 inhibitors at the time of AAV diagnosis. The 5-year survival probability was 90% for ...

Rising or critical antibody titers occurred at similar rates in fetal antigen-negative and -positive pregnancies, limiting their value for HDFN prediction. Monitoring for hemolytic disease of the ...

Navenibart is a monoclonal antibody inhibitor of plasma kallikrein that aims to provide rapid, sustained, and convenient HAE attack prevention. Navenibart, an investigational long-acting monoclonal ...